ScoreWhy is IRadimed Corp. ?
1
High Management Efficiency with a high ROE of 17.02%
2
The company is Net-Debt Free
3
Healthy long term growth as Operating profit has grown by an annual rate 94.60%
4
The company has declared Positive results for the last 8 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at USD 28.95 MM
- RAW MATERIAL COST(Y) Fallen by -0.56% (YoY)
- INVENTORY TURNOVER RATIO(HY) Highest at 1.78 times
5
With ROE of 23.76%, it has a attractive valuation with a 13.15 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 57.74%, its profits have risen by 16.9% ; the PEG ratio of the company is 3.4
6
High Institutional Holdings at 68.22%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
- Their stake has increased by 4% over the previous quarter.
7
Market Beating Performance
- The stock has generated a return of 57.74% in the last 1 year, much higher than market (S&P 500) returns of 25.41%
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to IRadimed Corp. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is IRadimed Corp. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
IRadimed Corp.
57.74%
3.41
34.27%
S&P 500
25.41%
1.92
13.25%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
21.45%
EBIT Growth (5y)
94.60%
EBIT to Interest (avg)
14.28
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.56
Sales to Capital Employed (avg)
0.86
Tax Ratio
20.79%
Dividend Payout Ratio
38.88%
Pledged Shares
0
Institutional Holding
68.22%
ROCE (avg)
58.93%
ROE (avg)
17.02%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
55
Industry P/E
Price to Book Value
13.15
EV to EBIT
45.64
EV to EBITDA
43.32
EV to Capital Employed
27.46
EV to Sales
14.24
PEG Ratio
3.36
Dividend Yield
0.88%
ROCE (Latest)
60.17%
ROE (Latest)
23.76%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend7What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD 28.95 MM
RAW MATERIAL COST(Y)
Fallen by -0.56% (YoY
INVENTORY TURNOVER RATIO(HY)
Highest at 1.78 times
DIVIDEND PER SHARE(HY)
Highest at USD 6.61
OPERATING PROFIT MARGIN(Q)
Highest at 35 %
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Here's what is working for IRadimed Corp.
Operating Cash Flow
Highest at USD 28.95 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Operating Profit Margin
Highest at 35 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Inventory Turnover Ratio
Highest at 1.78 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Dividend per share
Highest at USD 6.61
in the last five yearsMOJO Watch
Company is distributing higher dividend from profits generated
DPS (USD)
Raw Material Cost
Fallen by -0.56% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
